TGFB1 and neoplasm: For instance, TGFβ has been shown to be potently tumour suppressive in disease initiation as illustrated by the frequent mutations to signalling components, TGFβ-receptor-2 (TGFBR2), TGFBR1 and SMAD4 in human PDAC [6].